Are you Dr. Eckfeldt?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 27 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
420 Delaware St SE
# 760
Minneapolis, MN 55455Phone+1 612-626-0622Fax+1 612-626-2696
Summary
- Dr. John Eckfeldt, MD is a board certified pathologist in Minneapolis, Minnesota. He is currently licensed to practice medicine in Minnesota. He is affiliated with M Health Fairview University of Minnesota Medical Center and is a Professor at University of Minnesota Medical School.
Education & Training
- University of MinnesotaResidency, Pathology-Anatomic and Clinical, 1977 - 1978
- Minneapolis Veterans Affairs Health Care SystemInternship, Transitional Year, 1976 - 1977
- Perelman School of Medicine at the University of PennsylvaniaClass of 1976
Certifications & Licensure
- MN State Medical License 1977 - 2025
- American Board of Pathology Clinical Pathology
- American Board of Pathology Chemical Pathology
Clinical Trials
- Family Heart Study (FHS) Start of enrollment: 1992 Jun 01
- Family Blood Pressure Program - HyperGEN Start of enrollment: 1995 Sep 01
- Hemochromatosis and Iron Overload Screening Study (HEIRS) Start of enrollment: 2000 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- 2768 citationsEstimating glomerular filtration rate from serum creatinine and cystatin C.Lesley A. Inker, Christopher H. Schmid, Hocine Tighiouart, John H. Eckfeldt, Harold I. Feldman
The New England Journal of Medicine. 2012-07-04 - 103 citationsFibroblast Growth Factor‐23 and Incident Coronary Heart Disease, Heart Failure, and Cardiovascular Mortality: The Atherosclerosis Risk In Communities StudyPamela L. Lutsey, Alvaro Alonso, Elizabeth Selvin, James S. Pankow, Erin D. Michos
Journal of the American Heart Association. 2014-06-19 - 20 citationsRisk of ESRD and Mortality Associated With Change in Filtration Markers.Casey M. Rebholz, Lesley A. Inker, Yuan Chen, Menglu Liang, Meredith C. Foster
American Journal of Kidney Diseases. 2017-10-01
Authored Content
- Development of Nephrolithiasis in Asymptomatic Hyperuricemia: A Cohort StudyApril 2017
Press Mentions
- Diabetics Are Not Benefiting from Advances in Kidney CareFebruary 24th, 2011
- Biological Variability of Estimated GFR and Albuminuria in CKDJuly 19th, 2018